TMCnet News
MSLP, AFLB, Stock Report on Tuesday by CRWEWallstreet.com!MusclePharm® Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States announced the shipment of $1.4 million of multiple MusclePharm products from its new manufacturing partnership in the past six weeks. MSLP expects its new manufacturing partnership, which is CGMP and NSF certified, will ensure superior product quality and will improve shipping efficiencies in the coming quarters. All product development materials are qualified in their in-house laboratory equipped with the latest in analytical technology including High Pressure Liquid Chromatography (HPLC), Gas Chromatography (GC), and Fourier Transform Near Infrared (FT-NIR). They also have Atomic Absorption for Heavy Metals analysis and Solaris for accelerated microbial testing. More about MSLP at: www.musclepharm.com ***** A5 Laboratories Inc. (A5 Labs) (OTC.BB:AFLB) is pleased to provide an update on the company's business development activities for the month of July. On July 5, 2010 AFLB closed the acquisition of the Contract Research Organization (CRO) and laboratory assets as well as intellectual property relating to a method for the production of interferon products. Subsequently, the company entered into agreements with two CRO customers to provide a comprehensive range of services. Most recently AFLB submitted a provisional patent application to protect its technology for the production of interferon-based products. AFLB's lead product, VI-1718, has potential broad based applications for the treatment of certain types of cancer as well as multiple sclerosis and viral infections. During the month of July the company secured over $250,000 in equity financing. More about AFLB at: www.a5labs.com Sign Up For Free Stock Alerts At http://crwewallstreet.com/signup ****************************************************************************** THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEWallStreet publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEWallStreet.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.read more Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received twenty five thousand dollars in cash and twenty five thousand dollars in free trading stock from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB). Crown Equity Holdings, Inc. (CRWE.OB) has received eight thousand dollars in cash from a third party (Winning Media) for (one) day of advertising for A5 Laboratories Inc. (AFLB.OB). As a community-building service, TMCnet allows user submitted content which is not always proofed by TMCnet editors. If you feel this entry is of inferior quality or wish to report it for some reason, please forward the URL to "webedit [AT] tmcnet [DOT] com" with your comments. |